AI in Medical Diagnostics Market

Published on 2021-07-12

Report Code: 829

170-350 pages

AI in Medical Diagnostics Market : Segmented by Component (Software, Services); by Application (In Vivo Diagnostics, In Vitro Diagnostics); By End-User (Hospitals, Diagnostic Imaging centers, Diagnostic Laboratories, Others) and Region - Global Analysis of Market Size, Share & Trends for 2019-2020 and Forecasts to 2030

Buy Now

Add to cart

Table Of Content

Executive Summary
Global AI in Medical Diagnostics Market
1. Product Overview
2. Market Definition
3. Segmentation
4. Assumptions and Acronyms
Research Methodology
1. Research Objectives
2. Primary Research
3. Secondary Research
4. Forecast Model
5. Market Size Estimation
Average Pricing Analysis
Macro-Economic Indicators
Market Dynamics
1. Growth Drivers
2. Restraints
3. Opportunity
4. Trends
Correlation & Regression Analysis
1. Correlation Matrix
2. Regression Matrix
Recent Development, Policies & Regulatory Landscape
Risk Analysis
1. Demand Risk Analysis
2. Supply Risk Analysis
Global AI in Medical Diagnostics Market Analysis
1. Porters Five Forces
  1. Threat of New Entrants
  2. Bargaining Power of Suppliers
  3. Threat of Substitutes
  4. Rivalry
2. PEST Analysis
  1. Political
  2. Economic
  3. Social
  4. Technological
Global AI in Medical Diagnostics Market
1. Market Size & forecast, 2020A-2030F
  1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
Global AI in Medical Diagnostics Market: Market Segmentation
1. By Regions
  1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  2. Europe: (Germany, UK, France, Italy, Spain, and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  3. Asia-Pacific: (China, India, Japan, Australia and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  4. Latin America: (Brazil, Mexico, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  5. Middle East and Africa, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
2. By Component: Market Share (2020-2030F)
  1. Software, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  2. Service, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
3. By Application: Market Share (2020-2030F)
  1. In Vivo Diagnostics, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  2. In-Vitro Diagnostics, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
4. By End-User: Market Share (2020-2030F)
  1. Hospitals, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  2. Diagnostic imaging centers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  3. Diagnostic Laboratories, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  4. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

Company Profile

Microsoft Corporation
1. Company Overview
2. Company Total Revenue (Financials)
3. Market Potential
4. Global Presence
5. Key Performance Indicators
6. SWOT Analysis
7. Product Launch
NVIDIA
IBM
Intel
Siemens Healthineers
GE Healthcare
Digital Diagnostics
Xilinx
InformAI
Enlitic
Day Zero Diagnostics
Aidence
Butterfly Network, Inc.
Prognos
Zebra Medical Vision

Consultant Recommendation

**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.